BioSpace News Archive

Covis Pharma Group announced the appointment of Christine Poulin as Senior Vice President & General Manager, Canada, effective August 8, 2022.

Cordis, a global leader in cardiovascular technologies, today announced the start of the RADIANCY pre-market clinical study in Europe.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The need for urgent development of effective vaccines has driven demand within the global biologic excipients market.

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global orthodontics market is prophesized to make rapid strides along its growth trajectory mainly due to increased prevalence of oral diseases.

Iron is one of the most significant minerals required for the correct working of human bodies. Iron insufficiency prompts various medical problems, for example, anemia and could have a grave and direct association with the several of hospitalizations and deaths.

On the July 14, 2022, GenScript ProBio, a global CDMO, and DAAN Bio Therapeutics, an innovative new drug developer such as antibody treatments and cell therapy drugs, announced that they had entered into a strategic cooperation MOU concerning the development for innovation drug discovery & development.

Regeneron Pharmaceuticals, Inc. and Sanofi announced that a Phase 3 trial assessing the investigational use of Dupixent® in children aged 1 to 11 years with eosinophilic esophagitis met its primary endpoint of histological disease remission at 16 weeks with both higher and lower dose weight-tiered regimens.

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that its COVID-19 vaccine has been approved by the Brazilian Health Regulatory Agency for emergency use in children from 3 to 5 years old on 13 July.

Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, July 28, 2022.

Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday, August 4, 2022 , at 8:00 a.m. CDT to review fourth quarter 2022 financial results.